Debt to Equity Ratio: A measure of a company's financial leverage calculated by dividing its long-term debt by shareholders equity. Calculated as: Total Debt / Shareholders Equity
Oncobiologics, Inc. (OTLK) had Debt to Equity Ratio of -0.40 for the most recently reported fiscal year, ending 2024-09-30.
| Income Statement Financials | |
-- |
|
$-75.37M |
|
-- |
|
-- |
|
$71.70M |
|
$-71.70M |
|
$-3.66M |
|
$-75.36M |
|
$-75.36M |
|
$-75.37M |
|
$-75.37M |
|
$-75.37M |
|
$-75.37M |
|
$-71.70M |
|
$-71.59M |
|
18.55M |
|
18.55M |
|
$-4.06 |
|
$-4.06 |
|
| Balance Sheet Financials | |
$27.42M |
|
-- |
|
$1.41M |
|
$28.82M |
|
$42.55M |
|
-- |
|
$59.35M |
|
$101.90M |
|
$-73.08M |
|
$-73.08M |
|
$-73.08M |
|
23.91M |
|
| Cash Flow Statement Financials | |
$-68.79M |
|
-- |
|
$60.33M |
|
$23.39M |
|
$14.93M |
|
$-8.46M |
|
$5.39M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.64 |
|
-- |
|
-- |
|
-- |
|
|
Debt to Equity Ratio |
-0.40 |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-68.79M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
103.13% |
|
103.13% |
|
-261.48% |
|
103.13% |
|
$-3.06 |
|
$-3.71 |
|
$-3.71 |
|